MiMedx Group, Inc. ( MDXG) - Key Metrics
MDXG Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.80 | $0.10 | $0.17 | $0.17 |
| 2025Q3 | $0.77 | $0.11 | $0.20 | $0.17 |
| 2025Q2 | $0.67 | $0.07 | $0.10 | $0.10 |
| 2025Q1 | $0.60 | $0.05 | $0.04 | $0.03 |
MDXG Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 16.47 |
| 2025Q3 | ? | 15.42 |
| 2025Q2 | ? | 23.47 |
| 2025Q1 | ? | 39.84 |
MDXG Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.22% | ? |
| 2025Q4 | 2.46% | ? |
| 2025Q3 | 2.46% | ? |
| 2025Q2 | 1.57% | ? |
| 2025Q1 | 0.44% | ? |
MDXG
Price: $3.68
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.20 USD
P/E Ratio: 18.20
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 527584
Ebitda: 10.3 millionMarket Capitalization: 557.1 million